JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹35 Cr | ₹47 Cr | ₹6.91 Cr | ₹28 Cr | ₹12 Cr |
What is the latest Cash Flow from Operating Activities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹35 Cr |
Mar2023 | ₹47 Cr |
Mar2022 | ₹6.91 Cr |
Mar2021 | ₹28 Cr |
Mar2020 | ₹12 Cr |
How is Cash Flow from Operating Activities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹35 Cr | -24.63 | |
Mar2023 | ₹47 Cr | 574.79 | |
Mar2022 | ₹6.91 Cr | -75.50 | |
Mar2021 | ₹28 Cr | 137.46 | |
Mar2020 | ₹12 Cr | - |
Compare Cash Flow from Operating Activities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,599.2 Cr | -5.8% | -1.6% | 45.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | -5.8% |
-1.6% |
45.2% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses